Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients - Akebia Therapeutics (NASDAQ:AKBA)

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients - Akebia Therapeutics (NASDAQ:AKBA)

CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that after meeting with the U.S. Food and Drug Administration (FDA) it has not come to alignment on a path forward for the design of the VALOR clinical trial for the use of vadadustat to treat anemia in patients with late-stage chronic …